{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T13:05:23Z","timestamp":1783947923304,"version":"3.55.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["ejradiology.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Radiology"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.ejrad.2019.02.018","type":"journal-article","created":{"date-parts":[[2019,2,15]],"date-time":"2019-02-15T02:45:41Z","timestamp":1550198741000},"page":"148-152","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":49,"special_numbering":"C","title":["Breast MRI background parenchymal enhancement as an imaging bridge to molecular cancer sub-type"],"prefix":"10.1016","volume":"113","author":[{"given":"Giuseppe","family":"Dilorenzo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Telegrafo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"La Forgia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amato Antonio","family":"Stabile Ianora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1771-8337","authenticated-orcid":false,"given":"Marco","family":"Moschetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejrad.2019.02.018_bib0005","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1148\/rg.341135034","article-title":"Background parenchymal enhancement at breast MR imaging: normal patterns, diagnostic challenges, and potential for false-positive and false-negative interpretation","volume":"34","author":"Giess","year":"2014","journal-title":"Radiographics"},{"issue":"5","key":"10.1016\/j.ejrad.2019.02.018_bib0010","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.rcl.2007.07.002","article-title":"Diagnostic breast MR imaging: current status and future directions","volume":"45","author":"Morris","year":"2007","journal-title":"Radiol. Clin. North Am."},{"issue":"3","key":"10.1016\/j.ejrad.2019.02.018_bib0015","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.diii.2015.12.006","article-title":"Effect of background parenchymal enhancement on breast cancer detection with magnetic resonance imaging","volume":"97","author":"Telegrafo","year":"2016","journal-title":"Diagn. Interv. Imaging"},{"key":"10.1016\/j.ejrad.2019.02.018_bib0020","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1016\/j.ejrad.2014.05.007","article-title":"Background parenchymal enhancement in breast MRIs of breast cancer patients: impact on tumor size estimation","volume":"83","author":"Baek","year":"2014","journal-title":"Eur. J. Radiol."},{"issue":"1","key":"10.1016\/j.ejrad.2019.02.018_bib0025","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1148\/radiology.203.1.9122383","article-title":"Menstrual cycle and age: influence on parenchymal contrast medium enhancement in MR imaging of the breast","volume":"203","author":"M\u00fcller-Schimpfle","year":"1997","journal-title":"Radiology"},{"issue":"4","key":"10.1016\/j.ejrad.2019.02.018_bib0030","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/j.1075-122X.2005.21499.x","article-title":"Physiologic changes in breast magnetic resonance imaging during the menstrual cycle: perfusion imaging, signal enhancement, and influence of the T1 relaxation time of breast tissue","volume":"11","author":"Delille","year":"2005","journal-title":"Breast J."},{"issue":"2","key":"10.1016\/j.ejrad.2019.02.018_bib0035","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1148\/radiol.2015142304","article-title":"Are qualitative assessments of background parenchymal enhancement, amount of fibroglandular tissue on MR images, and mammographic density associated with breast cancer risk?","volume":"276","author":"Dontchos","year":"2015","journal-title":"Radiology"},{"key":"10.1016\/j.ejrad.2019.02.018_bib0040","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.2214\/AJR.09.2657","article-title":"Optimal timing of breast MRI examinations for premenopausal women who do not have a normal menstrual cycle","volume":"193","author":"Ellis","year":"2009","journal-title":"AJR Am. J. Roentgenol."},{"key":"10.1016\/j.ejrad.2019.02.018_bib0045","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1007\/s00330-011-2175-6","article-title":"Does the degree of background enhancement in breast MRI affect the detection and staging of breast cancer?","volume":"21","author":"Uematsu","year":"2011","journal-title":"Eur. Radiol."},{"issue":"6","key":"10.1016\/j.ejrad.2019.02.018_bib0050","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/tbj.12002","article-title":"Impact of tamoxifen on amount of fibroglandular tissue, background parenchymal enhancement, and cysts on breast magnetic resonance imaging","volume":"18","author":"King","year":"2012","journal-title":"Breast J."},{"issue":"3","key":"10.1016\/j.ejrad.2019.02.018_bib0055","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1007\/s11547-010-0513-4","article-title":"Correlation between breast density in mammography and background enhancement in MR mammography","volume":"115","author":"Cubuk","year":"2010","journal-title":"Radiol. Med."},{"issue":"3","key":"10.1016\/j.ejrad.2019.02.018_bib0060","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.ejrad.2010.07.019","article-title":"Background enhancement in breast MR: correlation with breast density in mammography and background echotexture in ultrasound","volume":"80","author":"Ko","year":"2011","journal-title":"Eur. J. Radiol."},{"issue":"2","key":"10.1016\/j.ejrad.2019.02.018_bib0065","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.mri.2015.10.014","article-title":"Breast MRI background parenchymal enhancement (BPE) correlates with the risk of breast cancer","volume":"34","author":"Telegrafo","year":"2016","journal-title":"Magn. Reson. Imaging"},{"issue":"2","key":"10.1016\/j.ejrad.2019.02.018_bib0070","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1002\/jmri.24495","article-title":"Does MRI breast \"density\" (degree of background enhancement) correlate with mammographic breast density?","volume":"40","author":"Hansen","year":"2014","journal-title":"J. Magn. Reson. Imaging"},{"issue":"July1","key":"10.1016\/j.ejrad.2019.02.018_bib0075","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1148\/radiol.11102156","article-title":"Background parenchymal enhancement at breast MR imaging and breast cancer risk","volume":"260","author":"King","year":"2011","journal-title":"Radiology"},{"issue":"March9","key":"10.1016\/j.ejrad.2019.02.018_bib0080","article-title":"Background parenchymal enhancement on preoperative magnetic resonance imaging; association with recurrence-free survival in breast cancer patients treated with neoadjuvant chemotherapy","volume":"95","author":"Choi","year":"2016","journal-title":"Medicine (Baltimore)"},{"issue":"September3","key":"10.1016\/j.ejrad.2019.02.018_bib0085","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1148\/radiol.15142192","article-title":"Association between parenchymal enhancement of the contralateral breast in dynamic contrast-enhanced MR imaging and outcome of patients with unilateral invasive breast cancer","volume":"276","author":"van der Velden","year":"2015","journal-title":"Radiology"},{"key":"10.1016\/j.ejrad.2019.02.018_bib0090","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.crad.2015.02.017","article-title":"Background parenchymal enhancement on breast MRI and mammographic breast density: correlation with tumour characteristics","volume":"70","author":"Kim","year":"2015","journal-title":"Clin. Radiol."},{"issue":"7","key":"10.1016\/j.ejrad.2019.02.018_bib0095","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0158573","article-title":"MRI background parenchymal enhancement is not associated with breast cancer","volume":"11","author":"Bennani-Baiti","year":"2016","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.ejrad.2019.02.018_bib0100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0143308","article-title":"Identifying triple-negative breast CancerUsing background parenchymal enhancement heterogeneity on dynamic contrast-enhanced MRI: a pilot radiomics study","volume":"10","author":"Wang","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ejrad.2019.02.018_bib0105","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1093\/annonc\/mdr304","article-title":"Strategies for subtypes\u2014dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011","volume":"22","author":"Goldhirsch","year":"2011","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.ejrad.2019.02.018_bib0110","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1200\/JCO.2009.25.6529","article-title":"American Society of Clinical Oncology\/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer","volume":"28","author":"Hammond","year":"2010","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ejrad.2019.02.018_bib0115","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1200\/JCO.2006.09.2775","article-title":"American Society of Clinical Oncology\/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer","volume":"25","author":"Wolff","year":"2007","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ejrad.2019.02.018_bib0120","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s10549-007-9632-6","article-title":"Epidemiology of basal-like breast cancer","volume":"109","author":"Millikan","year":"2008","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.ejrad.2019.02.018_bib0125","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1158\/1055-9965.EPI-10-0974","article-title":"Body size, physical activity, and risk of triple-negative and estrogen receptor-positive breast cancer","volume":"20","author":"Phipps","year":"2011","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"10.1016\/j.ejrad.2019.02.018_bib0130","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s10552-010-9709-0","article-title":"Reproductive history and risk of three breast cancer subtypes defined by three biomarkers","volume":"22","author":"Phipps","year":"2011","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.ejrad.2019.02.018_bib0135","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1200\/JCO.2007.14.4147","article-title":"Response to neoadjuvant therapy and longterm survival in patients with triple-negative breast cancer","volume":"26","author":"Liedtke","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ejrad.2019.02.018_bib0140","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1007\/s10549-008-0200-5","article-title":"Hazard of recurrence and adjuvant treatment effects over time in lymph node-negative breast cancer","volume":"116","author":"Dignam","year":"2009","journal-title":"Breast Cancer Res. Treat."},{"issue":"September 9","key":"10.1016\/j.ejrad.2019.02.018_bib0145","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1093\/annonc\/mdq754","article-title":"Differential efficacy of three cycles of CMF followed by tamoxifen in patients with ER-positive and ER-negative tumors: long-term follow up on IBCSG Trial IX","volume":"22","author":"Aebi","year":"2011","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.ejrad.2019.02.018_bib0150","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S1470-2045(09)70314-6","article-title":"Prognostic and predictive value of the 21- gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial","volume":"11","author":"Albain","year":"2010","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ejrad.2019.02.018_bib0155","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1200\/JCO.2007.14.4287","article-title":"Breast cancer subtype approximated by estrogen receptor, progesterone receptor, and HER-2 is associated with local and distant recurrence after breast-conserving therapy","volume":"26","author":"Nguyen","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ejrad.2019.02.018_bib0160","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.ijrobp.2009.04.059","article-title":"The association between biological subtype and isolated regional nodal failure after breast-conserving therapy","volume":"77","author":"Wo","year":"2010","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.ejrad.2019.02.018_bib0165","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s10549-010-1331-z","article-title":"Comparison of the prognostic and predictive utilities of the 21-gene recurrence score assay and adjuvant! For women with node-negative, ER-positive breast cancer: results from NSABP B-14 and NSABP B-20","volume":"127","author":"Tang","year":"2011","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.ejrad.2019.02.018_bib0170","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.clinimag.2018.05.008","article-title":"Evaluation of association between degree of background parenchymal enhancement on MRI and breast cancer subtype","volume":"51","author":"Ha","year":"2018","journal-title":"Clin. Imaging"},{"issue":"4","key":"10.1016\/j.ejrad.2019.02.018_bib0175","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1002\/jmri.25661","article-title":"Identifying relations between imaging phenotypes and molecular subtypes of breast cancer: model discovery and external validation","volume":"46","author":"Wu","year":"2017","journal-title":"J. Magn. Reson. Imaging"},{"issue":"September 9","key":"10.1016\/j.ejrad.2019.02.018_bib0180","article-title":"Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013","volume":"24","author":"Goldhirsch","year":"2013","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.ejrad.2019.02.018_bib0185","doi-asserted-by":"crossref","first-page":"518","DOI":"10.3332\/ecancer.2015.518","article-title":"Highlights from the 14th St Gallen International Breast Cancer conference 2015 in Vienna: dealing with classification, prognostication, and prediction refinement to personalize the treatment of patients with early breast cancer","volume":"9","author":"Esposito","year":"2015","journal-title":"Ecancermedicalscience"},{"key":"10.1016\/j.ejrad.2019.02.018_bib0190","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1093\/jnci\/djp082","article-title":"Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancer","volume":"101","author":"Cheang","year":"2009","journal-title":"J. Natl. Cancer Inst."},{"issue":"2","key":"10.1016\/j.ejrad.2019.02.018_bib0195","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s11547-012-0864-0","article-title":"Contrast-enhanced MR imaging of the breast: association between asymmetric increased breast vascularity and ipsilateral cancer in a consecutive series of 197 patients","volume":"118","author":"Verardi","year":"2013","journal-title":"Radiol. Med."}],"container-title":["European Journal of Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0720048X19300713?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0720048X19300713?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,3,27]],"date-time":"2019-03-27T22:10:34Z","timestamp":1553724634000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0720048X19300713"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":39,"alternative-id":["S0720048X19300713"],"URL":"https:\/\/doi.org\/10.1016\/j.ejrad.2019.02.018","relation":{},"ISSN":["0720-048X"],"issn-type":[{"value":"0720-048X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Breast MRI background parenchymal enhancement as an imaging bridge to molecular cancer sub-type","name":"articletitle","label":"Article Title"},{"value":"European Journal of Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejrad.2019.02.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}